Yosuke Kunishita
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
The impact of shared decision-making on quality of life in systemic lupus erythematosus practice: findings from the TRUMP2-SLE prospective cohort study.
Journal: Frontiers in immunology
Published: August 11, 2025
Comparative effectiveness and safety of peficitinib and abatacept for rheumatoid arthritis: a multicentre, inverse probability weighting analysis.
Journal: Modern rheumatology
Published: July 28, 2025
Gender differences in the clinical features and quality of life of Japanese patients with systemic lupus erythematosus: a cross-sectional study based on the LUNA registry.
Journal: Arthritis research & therapy
Published: February 09, 2025
Characteristic features of late-onset systemic lupus erythematosus: An observational study of data from the Lupus Registry of Nationwide Institutions.
Journal: Lupus
Published: September 03, 2024
Effect of Shared Decision-Making on Trust in Physicians in the Management of Systemic Lupus Erythematosus: The Trust Measurement for Physicians and Patients With Systemic Lupus Erythematosus Prospective Cohort Study.
Journal: Arthritis care & research
Published: January 31, 2024
Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry.
Journal: Frontiers in immunology
Published: May 23, 2023
Efficacy and safety of abatacept in patients with rheumatoid arthritis with previous malignancy.
Journal: Therapeutic advances in musculoskeletal disease
Published: April 21, 2023
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
Journal: International journal of hematology
Published: December 26, 2022
Immune checkpoint inhibitor-induced arthralgia is tightly associated with improved overall survival in cancer patients.
Journal: Rheumatology (Oxford, England)
Published: June 10, 2022
Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.
Journal: Frontiers in immunology
Published: March 21, 2022
Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus.
Journal: Lupus
Published: September 27, 2021
Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan.
Journal: Annals of the rheumatic diseases
Published: May 28, 2021
Last Updated: 09/26/2026